Atul Mukund Deshpande
Keine laufenden Positionen mehr
Profil
Atul Mukund Deshpande worked as an Associate Director at Sanofi, Inc. (China) from 2012 to 2014 and as an Executive Director & Chief Strategy Officer at HBM Holdings Ltd.
from 2018 to 2021.
He earned a doctorate degree from the University of California, Irvine in 2007, an MBA from Cranfield University in 2011, and an undergraduate degree from the University of Mumbai in 2000.
Ehemalige bekannte Positionen von Atul Mukund Deshpande
| Unternehmen | Position | Ende |
|---|---|---|
| HBM HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 25.04.2021 |
Sanofi, Inc. (China)
 Sanofi, Inc. (China) Pharmaceuticals: MajorHealth Technology Part of Sanofi, Inc. (China) is a Chinese company that manufactures pharmaceutical products for heart, kidney, and diabetes problems. The company is based in Shanghai, China. | Corporate Officer/Principal | 01.12.2014 |
Ausbildung von Atul Mukund Deshpande
| University of Mumbai | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
| Cranfield University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HBM HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Sanofi, Inc. (China)
Sanofi, Inc. (China) Pharmaceuticals: MajorHealth Technology Part of Sanofi, Inc. (China) is a Chinese company that manufactures pharmaceutical products for heart, kidney, and diabetes problems. The company is based in Shanghai, China. | Health Technology |
